Related Experiment Video
Updated: Jul 18, 2025

Iris Fixation via External Pentagram Suturing
Published on: May 5, 2022
Infectious crystalline keratopathy: A case series
Shalini Mohan1, Kunal Sahai, Vinita Gupta
1GSVM Medical College, Kanpur, India.
This case series details three patients with infectious crystalline keratopathy (ICK) post-penetrating keratoplasty. Prompt antibiotic treatment led to complete lesion resolution, highlighting effective management strategies for this rare corneal disease.
Area of Science:
- Ophthalmology
- Corneal Diseases
- Infectious Keratitis
Background:
- Infectious crystalline keratopathy (ICK) is a rare and potentially sight-threatening corneal infection.
- Penetrating keratoplasty (corneal transplant) can be a risk factor for developing ICK.
- This study focuses on ICK cases arising after corneal transplantation.
Observation:
- Three patients who underwent penetrating keratoplasty between 2010 and 2020 presented with ICK.
- Clinical examination revealed characteristic crystalline patterns indicative of ICK.
- Diagnosis was established based on clinical presentation.
Findings:
- All three patients were treated with broad-spectrum antibiotics.
- Complete resolution of the crystalline lesions was achieved in all cases with antibiotic therapy.
- The study highlights the successful management of ICK in post-keratoplasty patients.
Implications:
- Early clinical diagnosis and prompt broad-spectrum antibiotic treatment are crucial for managing ICK.
- This case series provides valuable insights into the clinical features and effective treatment of this resistant corneal infection.
- Understanding ICK management post-keratoplasty can improve patient outcomes and preserve vision.
More Related Videos
07:50A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
Published on: September 20, 2018
04:00Author Spotlight: Establishing a Practical and Cost-Effective Protocol for Corneal Sensitivity Testing in Clinical Settings
Published on: August 2, 2024